glp-1 travel case GLP-1's ✈️❄️ Traveling with meds, insulin,

Dopamine neurons modulate neural encoding and expression of depression-related behaviour

A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful weight loss while simultaneously protecting the heart, kidneys, and metabolic health

Before We Label It Resistant We must first rule out: 1 Poor blood pressure measurement technique 2 Medication non-adherence 3 White-coat hypertension (confirm with home or ambulatory monitoring) 4 Inadequate drug dosing 5 Clinical inertia Many cases are actually pseudo-resistant hypertension

Last reviewed: June 26, 2026 Last updated: June 26, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Always discuss potential risks with your doctor

[53] have demonstrated that GIPR agonism via tirzepatide can improve insulin sensitivity in the adipocytes of DIO rodents